Improving the quality of medication use in elderly patients: a not-so-simple prescription.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMID 12153368)

Published in Arch Intern Med on August 02, 2002

Authors

Jerry H Gurwitz, Paula Rochon, Food and Drug Administration (U.S.)

Articles citing this

Primary care clinicians' experiences with treatment decision making for older persons with multiple conditions. Arch Intern Med (2010) 2.56

Agreement between drugs-to-avoid criteria and expert assessments of problematic prescribing. Arch Intern Med (2009) 1.70

Quality of care for elderly residents in nursing homes and elderly people living at home: controlled observational study. BMJ (2003) 1.58

Qualitative insights into general practitioners views on polypharmacy. BMC Fam Pract (2010) 1.45

Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria--a population-based cohort study. Br J Clin Pharmacol (2005) 1.44

Potentially inappropriate medication prescriptions among elderly nursing home residents: their scope and associated resident and facility characteristics. Health Serv Res (2004) 1.40

An unintended consequence of electronic prescriptions: prevalence and impact of internal discrepancies. J Am Med Inform Assoc (2010) 1.36

Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. II. Drug disposal, waste reduction, and future directions. Environ Health Perspect (2003) 1.28

The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol (2004) 1.25

Effects of pharmacists' interventions on appropriateness of prescribing and evaluation of the instruments' (MAI, STOPP and STARTs') ability to predict hospitalization--analyses from a randomized controlled trial. PLoS One (2013) 1.18

Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care (2003) 1.15

Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly. Eur J Clin Pharmacol (2003) 1.15

Why most interventions to improve physician prescribing do not seem to work. CMAJ (2003) 1.12

Potentially inappropriate medication in geriatric patients: the Austrian consensus panel list. Wien Klin Wochenschr (2011) 1.08

Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomised study. Eur J Clin Pharmacol (2005) 1.07

Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs. PLoS One (2012) 1.04

Inappropriate benzodiazepine use in older adults and the risk of fracture. Br J Clin Pharmacol (2008) 0.93

Impact of inappropriate drug use on physical performance among a frail elderly population living in the community. Eur J Clin Pharmacol (2007) 0.85

The effect of community pharmacy-based interventions on patient health outcomes: a systematic review. Med Care Res Rev (2012) 0.85

Development of an adverse drug reaction risk assessment score among hospitalized patients with chronic kidney disease. PLoS One (2014) 0.84

Drug-related emergency department visits by elderly patients presenting with non-specific complaints. Scand J Trauma Resusc Emerg Med (2013) 0.83

Empowering older patients to engage in self care: designing an interactive robotic device. AMIA Annu Symp Proc (2011) 0.76

Comparison of treatment effect estimates for pharmacological randomized controlled trials enrolling older adults only and those including adults: a meta-epidemiological study. PLoS One (2013) 0.75

Articles by these authors

Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med (2006) 6.34

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA (2004) 5.25

Prescription drug use in pregnancy. Am J Obstet Gynecol (2004) 4.92

Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA (2008) 4.74

Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med (2007) 3.71

Health plan members' views about disclosure of medical errors. Ann Intern Med (2004) 3.69

The incidence of adverse drug events in two large academic long-term care facilities. Am J Med (2005) 3.43

Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med (2007) 3.34

Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA (2006) 3.20

Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med (2008) 3.06

Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med (2010) 2.51

The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med (2008) 2.46

Reader's guide to critical appraisal of cohort studies: 1. Role and design. BMJ (2005) 2.43

Variation in nursing home antipsychotic prescribing rates. Arch Intern Med (2007) 2.30

Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med (2007) 2.27

Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med (2003) 2.19

Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly. Arch Intern Med (2003) 2.18

Cost-related medication nonadherence in older patients with rheumatoid arthritis. J Rheumatol (2013) 2.17

A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data. Pharmacoepidemiol Drug Saf (2012) 2.11

Effect of computerized provider order entry with clinical decision support on adverse drug events in the long-term care setting. J Am Geriatr Soc (2008) 2.09

Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc (2004) 2.08

The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes (2008) 2.03

Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf (2013) 2.01

Injury in First Nations communities in Ontario. Can J Public Health (2009) 2.00

Medication errors among adults and children with cancer in the outpatient setting. J Clin Oncol (2008) 2.00

A critical review of methods to evaluate the impact of FDA regulatory actions. Pharmacoepidemiol Drug Saf (2013) 2.00

Prescribers' responses to alerts during medication ordering in the long term care setting. J Am Med Inform Assoc (2006) 1.92

Comparison of review articles published in peer-reviewed and throwaway journals. JAMA (2002) 1.89

Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med (2004) 1.86

Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes. Arch Intern Med (2010) 1.86

A systematic review of validated methods for identifying heart failure using administrative data. Pharmacoepidemiol Drug Saf (2012) 1.86

Validation of a surveillance case definition for arthritis. J Rheumatol (2005) 1.85

Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ (2005) 1.84

FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf (2006) 1.83

Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer (2007) 1.71

Effectiveness of thrombolytic therapy for acute myocardial infarction in the elderly: cause for concern in the old-old. Arch Intern Med (2002) 1.70

The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care (2005) 1.68

Strategies for detecting adverse drug events among older persons in the ambulatory setting. J Am Med Inform Assoc (2004) 1.68

Atypical antipsychotics and parkinsonism. Arch Intern Med (2005) 1.66

Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Manag Care (2004) 1.66

Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents. J Am Geriatr Soc (2004) 1.63

Clinical application of a computerized system for physician order entry with clinical decision support to prevent adverse drug events in long-term care. CMAJ (2006) 1.59

A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. Arch Intern Med (2003) 1.58

Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med (2004) 1.57

Patterns and predictors of mammography utilization among breast cancer survivors. Cancer (2006) 1.52

A demonstration of the impact of response bias on the results of patient satisfaction surveys. Health Serv Res (2002) 1.52

Pain management in nursing home residents with cancer. J Am Geriatr Soc (2015) 1.49

Communicating with patients about medical errors: a review of the literature. Arch Intern Med (2004) 1.48

Challenges of estimating health service utilization for osteoarthritis patients on a population level. J Rheumatol (2002) 1.48

Improving the quality of reporting of randomized controlled trials evaluating herbal interventions: implementing the CONSORT statement [corrected]. Explore (NY) (2006) 1.47

Can pay-for-performance take nursing home care to the next level? J Am Geriatr Soc (2008) 1.45

Canadian Cardiovascular Society Consensus Conference 2002: Management of heart disease in the elderly patient. Can J Cardiol (2004) 1.44

Chronic disease score as a predictor of hospitalization. Epidemiology (2002) 1.43

Beyond the prescription: medication monitoring and adverse drug events in older adults. J Am Geriatr Soc (2011) 1.43

Did Medicare Part D Affect National Trends in Health Outcomes or Hospitalizations? A Time-Series Analysis. Ann Intern Med (2015) 1.42

Incidence of delirium in older adults newly prescribed lithium or valproate: a population-based cohort study. J Clin Psychiatry (2005) 1.42

Computerized physician order entry with clinical decision support in the long-term care setting: insights from the Baycrest Centre for Geriatric Care. J Am Geriatr Soc (2005) 1.41

Predicting motor decline and disability in Parkinson disease: a systematic review. Arch Neurol (2002) 1.40

Trends in prehospital delay in patients with acute myocardial infarction (from the Worcester Heart Attack Study). Am J Cardiol (2008) 1.36

Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf (2007) 1.35

Costs associated with developing and implementing a computerized clinical decision support system for medication dosing for patients with renal insufficiency in the long-term care setting. J Am Med Inform Assoc (2008) 1.32

Creating a research data network for cardiovascular disease: the CVRN. Expert Rev Cardiovasc Ther (2008) 1.32

Twenty-year trends in the incidence of stroke complicating acute myocardial infarction: Worcester Heart Attack Study. Arch Intern Med (2008) 1.32

Quality of reporting of randomized controlled trials of herbal medicine interventions. Am J Med (2006) 1.31

Medical abbreviations: writing little and communicating less. Arch Dis Child (2008) 1.28

Adverse drug events resulting from patient errors in older adults. J Am Geriatr Soc (2007) 1.28

Gender and risk of adverse outcomes in heart failure. Am J Cardiol (2004) 1.26

Exclusion of older adults and women from recent trials of acute coronary syndromes. J Am Geriatr Soc (2011) 1.23

Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc (2005) 1.22

Disclosure of medical errors: what factors influence how patients respond? J Gen Intern Med (2006) 1.21

Medicare part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007. Med Care (2011) 1.21

Recommendations for reporting randomized controlled trials of herbal interventions: Explanation and elaboration. J Clin Epidemiol (2006) 1.20

Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study. J Clin Epidemiol (2002) 1.19

Medicare beneficiaries and free prescription drug samples: a national survey. J Gen Intern Med (2008) 1.18

Antidepressants for agitation and psychosis in dementia. Cochrane Database Syst Rev (2011) 1.18

Nurse-physician communication in the long-term care setting: perceived barriers and impact on patient safety. J Patient Saf (2009) 1.16

Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice. Arch Intern Med (2008) 1.16

Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence. BMJ (2003) 1.16

Computerized clinical decision support during medication ordering for long-term care residents with renal insufficiency. J Am Med Inform Assoc (2009) 1.14

Nursing home residents and enrollment in Medicare Part D. J Am Geriatr Soc (2009) 1.14

Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control. Am J Manag Care (2006) 1.14

Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis. J Clin Epidemiol (2005) 1.13

Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc (2013) 1.12

Initial patterns of use of COX-2 inhibitors by elderly patients in Ontario: findings and implications. CMAJ (2002) 1.12

Pay-for-performance in nursing homes. Health Care Financ Rev (2009) 1.11

Medication errors in the homes of children with chronic conditions. Arch Dis Child (2011) 1.11

Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program. Pharmacoepidemiol Drug Saf (2012) 1.10

Do-not-resuscitate orders in patients hospitalized with acute myocardial infarction: the Worcester Heart Attack Study. Arch Intern Med (2004) 1.10

Computerized physician order entry with clinical decision support in long-term care facilities: costs and benefits to stakeholders. J Am Geriatr Soc (2007) 1.10

Drug shortages and clinicians: no time for complacency. Arch Intern Med (2012) 1.09

Antipsychotic use among nursing home residents. JAMA (2013) 1.09

Declining length of stay for patients hospitalized with AMI: impact on mortality and readmissions. Am J Med (2010) 1.07

Narrowing gender differences in procedure use for acute myocardial infarction: insights from the Worcester heart attack study. J Gen Intern Med (2003) 1.07

Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure. Am J Cardiol (2007) 1.07

Prescribers and pharmaceutical representatives: why are we still meeting? J Gen Intern Med (2009) 1.07

Cognitive impairment and self-care in heart failure. Clin Epidemiol (2013) 1.05

Patient completion of laboratory tests to monitor medication therapy: a mixed-methods study. J Gen Intern Med (2012) 1.05

Cluster randomized trials to study the comparative effectiveness of therapeutics: stakeholders' concerns and recommendations. Pharmacoepidemiol Drug Saf (2009) 1.03